NCA HepatoPancreatoBiliary Pathway Board (NCHPBPB)
HepatoPancreatoBiliary (HPB) Pathway Board
The Pathway Board brings together healthcare professionals, clinical leaders, and multi-agency representatives to enhance patient outcomes, ensure service quality, and promote equitable care across the region.
HPB cancer in the North of Scotland
HPB cancers account for around 1400 new patients diagnosed in Scotland each year.
In the North, investigation and treatment of HPB cancers occurs in our three main cancer centres in Aberdeen, Dundee and Inverness.
The aim of this Pathway Board is to facilitate regional working between the centres, ensuring a focus on improving patient outcomes.
For more information on the symptoms, investigation and treatment of HPB cancers, please visit the NHS Inform website.
Pathway Board details
| Clinical Director | Stephen McNally, Consultant HPB Surgeon, NHS Highland |
| Terms of Reference | Published May 2019 |
Clinical Management Guidelines (CMGs)
Please note the CMGs are produced by the Scottish HPB Network (SHPBN).
| Title | Published |
| SHPBN Pancreatic Duodenal Cancer | May 2013 |
| SHPBN HepatoCellular Carcinoma | March 2016 |
| SHPBN Proximal Cholangiocarcinoma and Gallbladder | May 2019 |
Other guidelines
| Title |
| SHPBN Follow-up Guidelines |
| Scottish Cancer Referral Guidelines - HPB Cancers |
| Scottish Palliative Care Guidelines |
North of Scotland Quality Performance Indicator (QPI) Annual Reports
| HPB QPI Annual Report (2019 patients) |
| HPB QPI Annual Report (2018 patients) |
Quality Performance Indicator (QPI) National Reports
Please note the QPIs are reported nationally by the SHPBN. Links to national reports are provided below.